Revelation Biosciences Stock Shares Outstanding
REVBW Stock | USD 0.01 0 16.50% |
Revelation Biosciences fundamentals help investors to digest information that contributes to Revelation Biosciences' financial success or failures. It also enables traders to predict the movement of Revelation Stock. The fundamental analysis module provides a way to measure Revelation Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Revelation Biosciences stock.
Common Stock Shares Outstanding is likely to climb to about 240.1 K in 2024. Revelation | Shares Outstanding |
Revelation Biosciences Company Shares Outstanding Analysis
Revelation Biosciences' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Revelation Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Revelation Biosciences is extremely important. It helps to project a fair market value of Revelation Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Revelation Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Revelation Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Revelation Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Revelation Shares Outstanding Historical Pattern
Today, most investors in Revelation Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Revelation Biosciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Revelation Biosciences shares outstanding as a starting point in their analysis.
Revelation Biosciences Shares Outstanding |
Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition |
Revelation Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Revelation Biosciences has 0.0 of shares currently outstending. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
All Next | Launch Module |
Revelation Fundamentals
Return On Equity | -2.7 | ||||
Return On Asset | -0.51 | ||||
Number Of Shares Shorted | 17.31 K | ||||
EBITDA | (95.21 K) | ||||
Net Income | (120.25 K) | ||||
Cash And Equivalents | 4.14 M | ||||
Cash Per Share | 1.79 X | ||||
Total Debt | 5.56 M | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 2.58 X | ||||
Book Value Per Share | 0.62 X | ||||
Cash Flow From Operations | (7.29 M) | ||||
Earnings Per Share | (4.77) X | ||||
Beta | 0.15 | ||||
Total Asset | 12.21 M | ||||
Retained Earnings | (25.47 M) | ||||
Working Capital | 6.58 M | ||||
Net Asset | 12.21 M |
About Revelation Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Revelation Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revelation Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revelation Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.